Compare Sana Biotechnology Inc (SANA) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs United States Natural Gas Fund — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $1.03B), while United States Natural Gas Fund trades at $10.01. Which is the better fit depends on your goals.
| SANA | UNG | |
|---|---|---|
Market Cap | $1.03B | — |
Sector | Health | Commodities - Energy |
52-Week High | $5.92 | $16.90 |
52-Week Low | $2.68 | $9.63 |
Enterprise Value | $946.04M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.45, down 10.39% in the past 24 hours, reflecting bearish technical signals and negative profitability. The company reported a net loss of $244.17 million for 2025, with a price-to-book ratio of 6.68. Recent news includes investor conference presentations and a peer-reviewed publication in The New England Journal of Medicine highlighting clinical data.
Despite analyst consensus favoring a 'Buy' rating (81.82% of 11 analysts), the stock faces significant risks from negative cash flows, high losses, and potential fiduciary concerns. Upside hinges on successful clinical developments and improved financial performance, but current fundamentals suggest caution for investors.
UNG trades at $10.46, down 0.95% with a bearish technical signal from moving averages. The ETF faces headwinds from high natural gas production and storage levels, though weather-driven demand provides some support. Recent EIA forecasts project record natural gas supply and demand through 2027, creating a mixed fundamental backdrop for this futures-based commodity ETF.
The outlook remains challenged by oversupply concerns, though long-term demand growth from LNG exports and data center power needs offers potential upside. Key risks include commodity price volatility and the structural limitations of futures-based ETFs versus equity-based alternatives like FCG.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
